Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Down 67.7% in March

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 3,200 shares, a drop of 67.7% from the February 28th total of 9,900 shares. Based on an average daily trading volume, of 3,300 shares, the short-interest ratio is currently 1.0 days.

Clinuvel Pharmaceuticals Trading Down 4.6 %

Shares of OTCMKTS CLVLY traded down $0.35 during trading on Friday, reaching $7.28. The stock had a trading volume of 454 shares, compared to its average volume of 2,263. The business’s 50-day moving average price is $7.44 and its 200-day moving average price is $8.30. Clinuvel Pharmaceuticals has a fifty-two week low of $6.80 and a fifty-two week high of $11.40.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).